SHIFA KANJWAL MD
Prescription History 1982131256
Internal Medicine - Medical Oncology in Dallas, TX

Active since May 17, 2017PECOS EnrolledAccepts Medicare Assignment
6202 HARRY HINES BLVD, DALLAS, TX 75390(214) 645-3999 Get Directions

NPPES record last updated: September 3, 2024. Verified against the NPPES registry weekly; last sync: October 25, 2026.

Record update history: Sep 3, 2024, Jul 21, 2022, Aug 2, 2020 and 1 more (4 updates tracked since 2017).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for SHIFA KANJWAL MD, an active Medical Oncology specialist practicing in Dallas, TX. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 11 documented patient claims. Among these therapy options, the most frequently utilized medication is Prochlorperazine Maleate, which accounts for 11 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

1
Medication
11
Total Claims
11
30-Day Fills
Prochlorperazine Maleate
Most Prescribed · 11 claims
View details
1 medication · 2024 Medicare Part D
Medicare Part D medications prescribed by SHIFA KANJWAL MD in 2024, with prescription volumes, average cost per fill, and TX state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other TX PrescribersVs. TX Avg
Prochlorperazine Maleate11$10.74▼ below TX avg▼ Less than typical

About Prochlorperazine Maleate: This medication is used to treat severe nausea and vomiting from certain causes (for example, after surgery or cancer treatment). Show more ▾

Prochlorperazine belongs to a class of drugs known as phenothiazines. This medication is not recommended for use in children younger than 2 years or in children going through surgery. A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612)

In 2024, this provider wrote 11 Medicare prescriptions for Prochlorperazine Maleate, about a third of the volume of the typical Texas prescriber of this medication (29.2). Medicare paid an average of $10.74 per fill, versus $14.01 statewide.

How often this provider prescribes it

This provider
11
TX average
29.2

This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$10.74
TX average
$14.01

This provider's average cost per fill is below the TX average for this medication.

11
30-Day Fills
standardized to 30-day supplies
79
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average TX prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the TX average cost per fill.

About this data. The prescription history for SHIFA KANJWAL MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Medical Oncology prescribing approach at this Dallas, TX practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among TX prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.